Fusion AntibodiesFAB 
$0.04-8.33%24h
-8.33%24h
Global rank
Market cap$2.47M
Change 7d-5.71%
YTD Performance-22.35%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Fusion Antibodies (FAB)
As of December 2024, Fusion Antibodies has a market cap of $2.47M. This makes Fusion Antibodies the world's th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Fusion Antibodies from 2017 to 2024
-
Value:-
Market cap history of Fusion Antibodies from 2017 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $3.09M | -2.59% |
| 2023 | $3.18M | -90.56% |
| 2022 | $33.63M | -59.09% |
| 2021 | $82.20M | -11.29% |
| 2020 | $92.66M | 57.96% |
| 2019 | $58.66M | 44.04% |
| 2018 | $40.72M | -74.41% |
| 2017 | $159.16M | - |
FAB Market Cap Today is $2.47M -8.33% - 21 Dec 2024
View largest stocks by market cap 
